-
3 weeks ago | 
jamanetwork.com | Michael Liu |Lucas X. Marinacci |Rishi Wadhera |Sadiya Khan
Key PointsQuestion How does the burden of cardiometabolic risk factors and cardiovascular diseases differ between rural and urban areas of the US, and do health care access, lifestyle factors, and social risk factors contribute to any rural-urban differences in cardiovascular health? Findings In this national cross-sectional study of US adults, age-standardized rates of hypertension, hyperlipidemia, obesity, diabetes, and coronary heart disease were significantly higher in rural vs urban areas.
-
2 months ago | 
jamanetwork.com | Donald M. Lloyd-Jones |Sadiya Khan |Maryanne Demasi |Rita F. Redberg
Statins for Primary Prevention of Cardiovascular Disease—Reply In Reply We thank Dr Demasi and colleagues for sharing their perspectives. We judge that the statements we made are supported by the evidence and we stand by the rationale presented and the conclusions expressed in our Viewpoint. As we discussed, data from randomized clinical trials show net benefit of statin therapy for patient groups with 10-year major cardiovascular event rates as low as 3%.
-
Nov 17, 2024 | 
jamanetwork.com | Sadiya Khan |Gregg C. Fonarow
Sex-Specific Efficacy and Safety in HF Trials: Inclusion Is Only the First Step
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Misato Chimura, MD, PhD; Xiaowen Wang, MD, MPH; Pardeep S. Jhund, MBChB, MSc, PhD; Alasdair D. Henderson, PhD; Brian L. Claggett, PhD; Akshay S.
-
Jul 29, 2024 | 
jamanetwork.com | Sadiya Khan |Donald M. Lloyd-Jones
Statins for Primary Prevention of Cardiovascular Disease—With PREVENT, What’s a Clinician to Do?
Quantitative decision tools are ubiquitous in medicine, assisting with diagnosis, prognosis, and treatment decisions. In cardiovascular disease (CVD) prevention, multivariable risk scores have been used for decades to align the intensity of prevention efforts with the absolute risk of a given patient.
-
Jun 28, 2024 | 
healio.com | Scott Buzby |Richard Smith |Stephanie Leonard |Sadiya Khan
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The rate of chronic hypertension during pregnancy doubled in the U.S. since 2008. Antihypertensive use was unchanged despite updated guidelines on clinical BP management issued in 2017.
-
Jun 12, 2024 | 
jamanetwork.com | Sadiya Khan
Postpartum Remote Blood Pressure Monitoring—When Control Is of the Essence Postpartum Ambulatory Blood Pressure and New-Onset Hypertensive Disorders of Pregnancy Alisse Hauspurg, MD, MS; Kripa Venkatakrishnan, MPH; Latima Collins, MD; Malamo Countouris, MD, MS; Jacob Larkin, MD; Beth Quinn, RN; Nuzhat Kabir, BA; Janet Catov, PhD; Lara Lemon, PhD, PharmD; Hyagriv Simhan, MD New-onset hypertensive disorders of pregnancy (HDP), which include preeclampsia, eclampsia, and gestational hypertension,...
-
Jun 4, 2024 | 
nature.com | Andrew Perry |Eric Farber-Eger |Tomas Gonzales |Venkatesh L. Murthy |Laura A. Colangelo |Keenan A. Walker | +8 more
AbstractDespite the wide effects of cardiorespiratory fitness (CRF) on metabolic, cardiovascular, pulmonary and neurological health, challenges in the feasibility and reproducibility of CRF measurements have impeded its use for clinical decision-making. Here we link proteomic profiles to CRF in 14,145 individuals across four international cohorts with diverse CRF ascertainment methods to establish, validate and characterize a proteomic CRF score.
-
Mar 7, 2024 | 
onlinelibrary.wiley.com | Natalie A. Cameron |Sadiya Khan
Adverse pregnancy outcomes (APOs) are often conceptualised as a window into future cardiovascular disease (CVD) risk.
-
Dec 28, 2023 | 
jamanetwork.com | Philip Greenland |Donald M. Lloyd-Jones |Sadiya Khan |Xiuqing Guo
Heart artery blockages start with cholesterol deposits, or plaques, that build up in the heart artery walls. Over time, these plaques can become hardened, or calcified. The calcium in plaques can be measured by a coronary computed tomographic scan. The scan takes 10 to 15 minutes and does not require any intravenous contrast or dye.
-
Dec 6, 2023 | 
jamanetwork.com | Sadiya Khan |Clyde Yancy
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification Arnab K. Ghosh, MD, MSc, MA; Sara Venkatraman, MA; Michael G. Nanna, MD, MHS; Monika M. Safford, MD; Lisandro D. Colantonio, MD, PhD; Todd M. Brown, MD, MSPH; Laura C. Pinheiro, PhD, MPH; Eric D. Peterson, MD, MPH; Ann Marie Navar, MD, PhD; Madeline R.
